ozanimod

5 Drugs That Could Make Celgene the Best Biotech Stock of the Next Decade
Motley Fool
Wed, 09/27/17 - 11:22 am
Celgene
ozanimod
GED-0301
luspatercept
marizomib
CC-220
Ozanimod Could Drive Celgene’s Long-Term Growth
Market Realist
Fri, 08/11/17 - 11:25 am
ozanimod
Celgene
These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet
Motley Fool
Sun, 07/23/17 - 11:47 am
Biogen
aducanumab
JNJ
apalutamide
Eli Lilly
abemaciclib
AbbVie
Rova-T
Celgene
ozanimod
Biotechs Find Strength In Numbers In Treating Multiple Sclerosis
Investors Business Daily
Fri, 07/21/17 - 10:25 am
MS
multiple sclerosis
Roche
Celgene
Novartis
Biogen
ozanimod
Gilenya
Ocrevus
Extavia
Celgene touts ozanimod MS data, but disability benefit weak over rival med
Fierce Biotech
Mon, 05/22/17 - 09:41 am
Celgene
ozanimod
MS
multiple sclerosis
Biogen
Avonex
Celgene highlights MS drug in diversification push
BioPharma Dive
Thu, 04/27/17 - 05:47 pm
Celgene
MS
multiple sclerosis
ozanimod
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
Ozanimod Safety Still A Question Mark For Celgene
Seeking Alpha
Thu, 02/23/17 - 09:13 am
Celgene
ozanimod
MS
multiple sclerosis
Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?
Motley Fool
Mon, 02/20/17 - 10:04 am
Celgene
ozanimod
MS
multiple sclerosis
Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial
TheStreet.com
Fri, 02/17/17 - 10:00 am
Celgene
ozanimod
clinical trials
MS
multiple sclerosis
What's Next For Celgene
Motley Fool
Wed, 01/11/17 - 10:13 am
Celgene
JPMHC 2017
Otezla
ozanimod
Revlimid
Pomalyst
Did Biogen Just Throw in the Towel to Celgene?
Motley Fool
Wed, 01/4/17 - 10:49 am
Biogen
Celgene
MT-1303
autoimmune disease
ozanimod
Celgene Boldly Targeting $6 Billion (or More) in New Business
Motley Fool
Tue, 11/1/16 - 09:49 am
Celgene
Otezla
autoimmune disease
ozanimod
Mongersen
Biogen quietly whisks away its $544M autoimmune rival to Celgene
Endpoints
Wed, 10/26/16 - 09:28 am
Biogen
Celgene
autoimmune disease
amiselimod
ozanimod
7 Reasons Celgene Is the Best Bet in Biotech
Motley Fool
Tue, 10/18/16 - 09:25 am
Celgene
ozanimod
CAR-T
CC-122
CC-220
demcizumab
Mongersen
AVL292
Celgene Is Building an Autoimmune Empire -- and No One Is Talking About It
Motley Fool
Sun, 10/2/16 - 10:19 am
Celgene
autoimmune disease
Otezla
ozanimod
GED-0301
The Most Exciting Drug in Celgene's Pipeline
Motley Fool
Wed, 09/21/16 - 10:46 pm
Celgene
ozanimod
autoimmune disease
Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons
TheStreet.com
Fri, 07/15/16 - 10:41 am
Celgene
Crohn's Disease
GED-0301
Otezla
ozanimod
Arena Investors Hope Celgene Trial A Harbinger For Future Returns
Seeking Alpha
Sat, 03/19/16 - 01:52 pm
Arena Pharmaceuticals
Celgene
ozanimod
APD334
ulcerative colitis
Is This a Potential $7 Billion Waste for Celgene Corporation?
Motley Fool
Fri, 01/8/16 - 09:39 am
Celgene
Biogen
multiple sclerosis
ozanimod
Receptos

Pages